China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The influence of esketamine combined with remimazolam anesthesia on postoperative sleep and recovery quality in patients with end-stage renal disease'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130454
Registration Time: 2026/08/20
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Zhengzhou University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338881
Published by HT Digital Content Services with permission from Health Daily Digest....